|
Showing 1 - 8 of
8 matches in All Departments
Health care delivery, therapies and pharmaceuticals face major
changes throughout the industrial world. As cost containment
strategies are introduced by governments, as payers become more
conscious and influential in their decisions about shaping
therapies, and as consumers become more involved in directing their
own health care, health care providers and pharmaceutical companies
are being challenged to rethink the way they do business. This
volume explores these changes and the potential responses. Parallel
developments in health care delivery, information systems,
pharmaceutical discovery and development are explored in Europe,
the U.S. and Japan. Alternative futures or scenarios of health
systems in 2010 summarize this diversity in the context of economic
growth and economic hard times. This book explores the future of
biomedical science by considering how the social, political and
economic context in health care delivery and pharmaceutical
industry will evolve. There is a slight chance that the future will
be a successful extrapolation of the present, far more likely are
scenarios which forecast major changes in the paradigms of medicine
and health policy. The papers and scenarios in this book review
that broader range of change.
This scarce antiquarian book is a selection from Kessinger
Publishing's Legacy Reprint Series. Due to its age, it may contain
imperfections such as marks, notations, marginalia and flawed
pages. Because we believe this work is culturally important, we
have made it available as part of our commitment to protecting,
preserving, and promoting the world's literature. Kessinger
Publishing is the place to find hundreds of thousands of rare and
hard-to-find books with something of interest for everyone
|
|